Dr. Motohiro Nishida completed the doctoral program at the University of Tokyo
(Graduate School of Pharmaceutical Sciences) in March 2001. His doctoral thesis was
‘Endogenous cardioprotective signaling activated by oxidative modification of Gαi and Gαo proteins’. Specializing
cardiovascular pharmacology and physiology, he experienced an Assistant Professor at the National Institute for
Physiological Sciences (NIPS) in National Institutes of Natural Sciences, an Associate Professor at Kyushu University,
and became a Professor at NIPS from 2013. He became a cross-appointment Professor at Kyushu University,
Graduate School of Pharmaceutical Sciences from 2015. From 2020, he also became a Director at the Drug
Discovery Research Center of Graduate School of Pharmaceutical Sciences, Kyushu University. He has consistently
studied on the CysSH modification-dependent regulation of G protein signaling in the heart, including heterotrimeric
Gi family proteins (Nature 2000), H-Ras small GTPase (Nature Chem. Biol., 2012) and dynamin-related G protein
Drp1 (Nature Commun., 2017; Sci. Signal, 2019; Nature Commun, 2025). He establishes a semi-quantitative bio
imaging technique using supersulfide-selective fluorescence probes and proteomic analysis to detect endogenous
supersulfidated proteins in cells and tissues. He also studies on Zn2+-permeable TRPC channels contributing to
baroreflex-dependent enhancement of cardiac positive inotropy (Nature Commun, 2022).